FDA Drug recall D-1545-2016
C-PAP/PHEN/PROST/ATROP 150/5/5 (Papaverine 150mg/Phentolamine 5mg/Prostaglandin 50mcg/Atropine 0.04mg injection), Rx, 10 ml vials contain 5…
- FDA Drug
- Class II
- terminated
- Published 2016-10-05
On 2016-10-05 the FDA classified a Class II recall of C-PAP/PHEN/PROST/ATROP 150/5/5 (Papaverine 150mg/Phentolamine 5mg/Prostaglandin 50mcg/Atropine 0.04mg injection), Rx, 10 ml vials contain 5… by Pharmacy Plus, citing lack of Assurance of Sterility.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1545-2016 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2016-07-26 |
| Published | 2016-10-05 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Pharmacy Plus |
| Distribution | MS |
Product
C-PAP/PHEN/PROST/ATROP 150/5/5 (Papaverine 150mg/Phentolamine 5mg/Prostaglandin 50mcg/Atropine 0.04mg injection), Rx, 10 ml vials contain 5.8 ml solution, Vital Care COMPOUNDER, Hattiesburg, MS 39402
Reason
Lack of Assurance of Sterility
Identifiers
| code_info | Lot# 397877, USE BY 1-6-17 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1545-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.